The Effect of Royal Vaginal Gel Compared to IUI Technique on Fertility Rate of Women With Low-fertility Husbands
Male Infertility and Complementary Treatment
1 other identifier
interventional
54
0 countries
N/A
Brief Summary
The present Pocock clinical trial study was conducted In the city of Mashhad in Iran between 2015 and 2016. The study inclusion criteria were men with low fertility of sperm motility\<25% and total motility \<50% (asthenozoospermia), no history of endocrine diseases, no diabetes men, no hormonal problems in their wives, and a healthy salpingography in their wives. The study subjects were voluntarily assigned to royal gel and IUI groups. In royal gel group, 5 grams of royal gel was used after menstruation and every other night before and after intercourse. IUI group received 75 units of FSH from the second day of the cycle. Then vaginal ultrasound was performed from the sixth day of menstrual cycle to determine the right size of follicle. 10000 units of HCG was administered when follicle diameter reached 16mm, and the study subject was prepared for IUI 32-36 hours later. Each subject alternately swapped groups following fertility failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2017
CompletedFirst Submitted
Initial submission to the registry
February 18, 2018
CompletedFirst Posted
Study publicly available on registry
March 13, 2018
CompletedMarch 13, 2018
March 1, 2018
1.7 years
February 18, 2018
March 6, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Occurrence of pregnancy
Occurrence of pregnancy be detected by B-HCG test
Three months after intervention
Secondary Outcomes (1)
confirmation of pregnancy
Three months after intervention
Study Arms (2)
Royal jelly
EXPERIMENTALThe study subjects included healthy women who had husbands with male-factor infertility problems.
IUI group
ACTIVE COMPARATORThe study subjects included in IUI group were healthy women who had husbands with male-factor infertility problems.
Interventions
The study subjects in the Royal jelly group used 10 ml of the vaginal Royal jell few minutes before and few minutes after intercourse one day after the end of menstruation for two weeks.
Subjects in IUI group received 75 units of FSH from the second day of the cycle.
Eligibility Criteria
You may qualify if:
- Male-factor infertility (defined as total sperm motility\<40% and sperm motility\<20%)
- Normal hormonal profile in women
- Normal hysterosalpingography report
- Regular sexual relationships
You may not qualify if:
- Ovulation dysfunction
- History of sexually transmitted diseases in women and men
- Hormonal disorders in men and women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tahereh Fathi Najafi, Instructor
Midwifery department, Islamic Azad Medical University, Mashhad branc, Mashhad, Iran
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Narjes Bahri
Study Record Dates
First Submitted
February 18, 2018
First Posted
March 13, 2018
Study Start
January 1, 2016
Primary Completion
September 20, 2017
Study Completion
December 10, 2017
Last Updated
March 13, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share